REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

FDA Peptide Drugs

Browse FDA-registered peptide and peptide-derived drugs. Filter by category or search by brand or generic name.

49 Results

Mounjaro

Tirzepatide

DRUG

Eli Lilly and Company

SUBCUTANEOUS INJECTION

Natrecor

Nesiritide

DRUG

Janssen (Johnson & Johnson)

IV INFUSION

Norditropin

Somatropin (recombinant HGH)

DRUG

Novo Nordisk A/S

SUBCUTANEOUS INJECTION

Nutropin AQ

Somatropin (recombinant HGH)

DRUG

Genentech Inc. (Roche)

SUBCUTANEOUS INJECTION

Omnitrope

Somatropin (recombinant HGH)

DRUG

Sandoz (Novartis)

SUBCUTANEOUS INJECTION

Orgovyx

Relugolix

DRUG

Myovant Sciences

ORAL TABLET

Orilissa

Elagolix

DRUG

AbbVie Inc.

ORAL TABLET

Ozempic

Semaglutide

DRUG

Novo Nordisk A/S

SUBCUTANEOUS INJECTION

Pitocin

Oxytocin

DRUG

Various manufacturers (Pfizer / Fresenius Kabi)

IV / IM INJECTION

Prialt

Ziconotide

DRUG

Jazz Pharmaceuticals

INTRATHECAL INFUSION

Rybelsus

Semaglutide

DRUG

Novo Nordisk A/S

ORAL TABLET

Saizen

Somatropin (recombinant HGH)

DRUG

EMD Serono (Merck KGaA)

SUBCUTANEOUS INJECTION

Sandostatin

Octreotide

DRUG

Novartis Pharmaceuticals

SC INJECTION / IV

Saxenda

Liraglutide

DRUG

Novo Nordisk A/S

SUBCUTANEOUS INJECTION

Signifor

Pasireotide

DRUG

Recordati Rare Diseases Inc.

SC INJECTION / IM (LAR)

Skytrofa

Lonapegsomatropin

DRUG

Ascendis Pharma

SUBCUTANEOUS INJECTION

Sogroya

Somapacitan

DRUG

Novo Nordisk A/S

SUBCUTANEOUS INJECTION

Somatuline Depot

Lanreotide

DRUG

Ipsen Biopharmaceuticals Inc.

DEEP SC INJECTION

Synarel

Nafarelin

DRUG

Pfizer Inc.

NASAL SPRAY

Trulance

Plecanatide

DRUG

Salix Pharmaceuticals

ORAL TABLET
Prev2 / 3Next

Data Source: Drug data is sourced from the openFDA API. This data may not reflect the most current information. Always verify drug information with official FDA resources or a licensed healthcare professional.

Peptide Contacts provides research-based summaries for informational purposes only. We do not host, distribute, or endorse vendor documentation. All certificates of analysis, GMP certificates, and vendor communications must be requested and verified directly by the buyer. Nothing on this platform constitutes legal, medical, or professional advice. Users are solely responsible for verifying vendor credentials and ensuring compliance with all applicable local, state, and federal laws before purchasing any research chemicals. Use of this platform constitutes acceptance of full personal responsibility.